| SCHEDULE OF GRANTED AND ISSUED STOCK AWARDS |
Issuances
under the 2021 Stock Plan in the period January 1 and June 30, 2025
SCHEDULE OF GRANTED AND ISSUED STOCK AWARDS
| Date |
|
|
#
Shares |
|
|
Amount |
|
|
Price/Share |
|
|
Type |
|
Notice |
|
| 1/01/2025 |
|
|
|
5,520,101 |
|
|
$ |
481,057 |
|
|
$ |
0.087 |
|
|
|
|
|
|
| 1/06/2025 |
* |
|
|
634,921 |
|
|
|
43,045 |
|
|
|
0.067 |
|
|
stipend |
|
affiliate |
|
| 1/06/2025 |
|
|
|
164,731 |
|
|
|
11,037 |
|
|
|
0.067 |
|
|
stipend |
|
|
|
| 1/06/2025 |
* |
|
|
1,315,780 |
|
|
|
88,031 |
|
|
|
0.067 |
|
|
bonus |
|
affiliate |
|
| 1/06/2025 |
|
|
|
1,134,220 |
|
|
|
78,914 |
|
|
|
0.067 |
|
|
bonus |
|
|
|
| 5/12/2026 |
|
|
|
156,255 |
|
|
|
21,876 |
|
|
|
0.140 |
|
|
stipend |
|
affiliates |
|
| 5/12/2026 |
|
|
|
110,384 |
|
|
|
15,454 |
|
|
|
0.140 |
|
|
stipend |
|
|
|
| 6/30/2025 |
|
|
|
9,036,392 |
|
|
$ |
739,889 |
|
|
$ |
0.081 |
|
|
|
|
|
|
There
has been no issuance under the 2021 Stock Plan in the period January 1 and June 30, 2026
| Date |
|
|
#
Shares |
|
|
Amount |
|
|
Price/Share |
|
|
Type |
|
Notice |
|
| 6/30/2026 |
|
|
|
10,062,844 |
|
|
$ |
809,407 |
|
|
$ |
0.080 |
|
|
|
|
|
|
Shares
awarded, but not yet issued, under the 2021 Stock Plan at June 30, 2026:
| Date |
|
|
#
Shares |
|
|
Amount |
|
|
Price/Share |
|
|
Type |
|
Notice |
|
| 1/01/2026 |
* |
|
|
1,081,875 |
|
|
$ |
82,006 |
|
|
$ |
0.076 |
|
|
stipend |
|
affiliate |
|
| 1/01/2026 |
|
|
|
150,250 |
|
|
|
11,389 |
|
|
|
0.076 |
|
|
stipend |
|
|
|
| 1/30/2026 |
* |
† |
|
30,000,000 |
|
|
|
1,278,600 |
|
|
|
0.043 |
|
|
performance
grant |
|
affiliate |
|
| 3/31/2026 |
|
|
|
254,240 |
|
|
|
11,415 |
|
|
|
0.045 |
|
|
stipend |
|
|
|
| 6/30/2026 |
|
|
|
300,568 |
|
|
|
7,815 |
|
|
|
0.026 |
|
|
stipend |
|
|
|
| 6/30/2026 |
|
|
|
31,786,933 |
|
|
$ |
1,391,225 |
|
|
$ |
0.044 |
|
|
|
|
|
|
| * |
The
shares will be issued as shares of Preferred Stock, but are for comparison purposes expressed as Common share equivalents in this
table. |
| † |
The
Board of Directors awarded the CEO 6,000,000 Preferred Shares, a 1:5 conversion, as a performance grant in recognition for his role
in advancing capital funding initiatives and establishing a distribution agreement for dietary supplements. |
| |
|
| |
The
Company claims an exemption from the registration requirements of the Securities Act for the compensatory benefit plan pursuant to
Rule 701 of the Securities Act. |
|